T. Bass

发表

Quantitative magnetic resonance perfusion imaging detects anatomic and physiologic coronary artery disease as measured by coronary angiography and fractional flow reserve.

N. Wilke, D. Angiolillo, M. Costa, 2007, Journal of the American College of Cardiology.

Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectives.

C. Macaya, A. Fernández-Ortiz, D. Angiolillo, 2007, Journal of the American College of Cardiology.

Operator radiation exposure and physical discomfort during a right versus left radial approach for coronary interventions: a randomized evaluation.

D. Angiolillo, M. Zenni, Luis A. Guzmán, 2014, JACC. Cardiovascular interventions.

Prasugrel Versus Ticagrelor in Patients With CYP2C19 Loss-of-Function Genotypes

L. Been, D. Angiolillo, F. Franchi, 2020, JACC. Basic to translational science.

Coronary hemodynamic effects of angiotensin inhibition by captopril and teprotide in patients with congestive heart failure.

J. Halperin, T. Ryan, D. Faxon, 1982, The American journal of cardiology.

Adaptation to the stress of tachycardia in patients with coronary artery disease: insight into the mechanism of the warm-up phenomenon.

H. Gewirtz, T. Bass, D. Williams, 1985, Circulation.

Effects of dabigatran on the cellular and protein phase of coagulation in patients with coronary artery disease on dual antiplatelet therapy with aspirin and clopidogrel

D. Angiolillo, F. Franchi, F. Rollini, 2015, Thrombosis and Haemostasis.

Haemostatic profiles assessed by thromboelastography in patients with end-stage renal disease

N. Nahman, Masafumi Ueno, D. Angiolillo, 2011, Thrombosis and Haemostasis.

Cigarette Smoking and Antiplatelet Effects of Aspirin Monotherapy Versus Clopidogrel Monotherapy in Patients with Atherosclerotic Disease: Results of a Prospective Pharmacodynamic Study

D. Angiolillo, F. Franchi, F. Rollini, 2014, Journal of Cardiovascular Translational Research.

Cigarette smoking is associated with a dose-response effect in clopidogrel-treated patients with diabetes mellitus and coronary artery disease: results of a pharmacodynamic study.

Masafumi Ueno, D. Angiolillo, D. Capodanno, 2012, JACC. Cardiovascular interventions.

Usefulness of cardiac magnetic resonance imaging for coronary artery disease detection.

N. Wilke, D. Angiolillo, S. Shoemaker, 2007, Minerva cardioangiologica.

ACCF/AHA/SCAI 2013 Update of the Clinical Competence Statement on Coronary Artery Interventional Procedures

Andrew Wang, I. Piña, J. Halperin, 2013, Circulation.

Strategies for drug‐eluting stent treatment of bifurcation coronary artery disease in the United States: Insights from the e‐Cypher S.T.L.L.R.Trial

D. Angiolillo, H. Bezerra, M. Tannenbaum, 2009, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Coronary thrombi increase PTCA risk. Angioscopy as a clinical tool.

P. Teirstein, R. Smalling, A. Karsan, 1996, Circulation.

Current antiplatelet therapies: benefits and limitations.

D. Angiolillo, Luis A. Guzmán, T. Bass, 2008, American heart journal.

Percutaneous recanalization of chronic total occlusions: wherein lies the body of proof?

G. Stone, G. Dangas, R. Mehran, 2013, American heart journal.

Percutaneous coronary intervention versus coronary artery bypass graft surgery in left main coronary artery disease: a meta-analysis of randomized clinical data.

G. Stone, M. Morice, D. Capodanno, 2011, Journal of the American College of Cardiology.

Pharmacodynamic Effects of Vorapaxar in Patients With and Without Diabetes Mellitus

L. Been, V. Kairouz, D. Angiolillo, 2019, JACC. Basic to translational science.

Effects of Edoxaban on the Cellular and Protein Phase of Coagulation in Patients with Coronary Artery Disease on Dual Antiplatelet Therapy with Aspirin and Clopidogrel: Results of the EDOX-APT Study

L. Been, J. Moon, V. Kairouz, 2019, Thrombosis and Haemostasis.

Anatomical and physiologic assessments in patients with small coronary artery disease: final results of the Physiologic and Anatomical Evaluation Prior to and After Stent Implantation in Small Coronary Vessels (PHANTOM) trial.

J. E. Sousa, C. Macaya, M. Sabaté, 2007, American heart journal.

Revascularization of Unprotected Left Main Coronary Artery Disease: Implications of Evolving Data on Clinical Practice.

D. Capodanno, T. Bass, 2016, Circulation. Cardiovascular interventions.

Pharmacodynamic Effects of Ticagrelor Dosing Regimens in Patients on Maintenance Ticagrelor Therapy: Results From a Prospective, Randomized, Double-Blind Investigation.

D. Angiolillo, F. Franchi, F. Rollini, 2015, JACC. Cardiovascular interventions.

Impact of P2Y(12) inhibitory effects induced by clopidogrel on platelet procoagulant activity in type 2 diabetes mellitus patients.

D. Angiolillo, S. Shoemaker, M. Zenni, 2009, Thrombosis research.

Pharmacodynamic Effects of Different Aspirin Dosing Regimens in Type 2 Diabetes Mellitus Patients With Coronary Artery Disease

Masafumi Ueno, D. Angiolillo, D. Capodanno, 2011, Circulation. Cardiovascular interventions.

Multiple plaque morphologies in a single coronary artery: insights from volumetric intravascular ultrasound

N. Wilke, M. Costa, P. Panse, 2004, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Effects of cangrelor in coronary artery disease patients with and without diabetes mellitus: an in vitro pharmacodynamic investigation

Masafumi Ueno, D. Angiolillo, D. Capodanno, 2013, Journal of Thrombosis and Thrombolysis.

Impact of adjunctive cilostazol therapy on platelet function profiles in patients with and without diabetes mellitus on aspirin and clopidogrel therapy

Masafumi Ueno, D. Angiolillo, D. Capodanno, 2011, Thrombosis and Haemostasis.

Debulking does not benefit patients undergoing intracoronary beta‐radiation therapy for in‐stent restenosis: Insights from the START trial

W. Laskey, M. Savage, J. Popma, 2003, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Effects of the Peripheral Opioid Receptor Antagonist Methylnaltrexone on the PK and PD Profiles of Ticagrelor in Patients With Coronary Artery Disease Treated With Morphine.

L. Been, D. Angiolillo, F. Franchi, 2019, JACC. Cardiovascular interventions.

Impaired responsiveness to the platelet P2Y12 receptor antagonist clopidogrel in patients with type 2 diabetes and coronary artery disease.

Masafumi Ueno, D. Angiolillo, F. Franchi, 2014, Journal of the American College of Cardiology.

Percutaneous coronary interventions in ST-segment-elevation myocardial infarction: shifting paradigms and future perspectives.

D. Angiolillo, T. Bass, 2013, Circulation. Cardiovascular interventions.

Impact of insulin receptor substrate-1 genotypes on platelet reactivity and cardiovascular outcomes in patients with type 2 diabetes mellitus and coronary artery disease.

E. Trabetti, G. Malerba, P. Pignatti, 2011, Journal of the American College of Cardiology.

Coronary Artery Disease Impact of Insulin Receptor Substrate-1 Genotypes on Platelet Reactivity and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease

E. Trabetti, G. Malerba, P. Pignatti, 2011 .

Prolonged survival in a patient with primary angiosarcoma of the heart.

D. Conetta, T. Bass, R. Percy, 1987, American heart journal.

Multi-Hospital Eastern Atlantic Restenosis Trial. II: A placebo-controlled trial of thromboxane blockade in the prevention of restenosis following coronary angioplasty.

M. Savage, S. Goldberg, A. Bove, 1991, American heart journal.

Effect of thromboxane A2 blockade on clinical outcome and restenosis after successful coronary angioplasty. Multi-Hospital Eastern Atlantic Restenosis Trial (M-HEART II)

M. Savage, D. Fischman, S. Goldberg, 1995, Circulation.

Multi-Hospital Eastern Atlantic Restenosis Trial: design, recruitment, and feasibility. M-HEART Investigators.

M. Savage, S. Goldberg, J. Hirshfeld, 1990, Catheterization and cardiovascular diagnosis.

Long-term outcomes in patients undergoing coronary stenting on dual oral antiplatelet treatment requiring oral anticoagulant therapy.

A. Gavazzi, G. Musumeci, R. Rossini, 2008, The American journal of cardiology.

Pharmacodynamic effects of cangrelor on platelet P2Y12 receptor-mediated signaling in prasugrel-treated patients.

D. Angiolillo, F. Franchi, F. Rollini, 2014, JACC. Cardiovascular interventions.

Acknowledging a failed strategy

T. Bass, 2009, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Impact Of Chronic Kidney Disease On The Pharmacodynamic And Pharmacokinetic Effects Of Ticagrelor In Patients With Diabetes Mellitus And Coronary Artery Disease.

L. Been, D. Angiolillo, F. Franchi, 2021, European heart journal. Cardiovascular pharmacotherapy.

Impact of chronic kidney disease on platelet function profiles in diabetes mellitus patients with coronary artery disease taking dual antiplatelet therapy.

Masafumi Ueno, C. Macaya, A. Fernández-Ortiz, 2010, Journal of the American College of Cardiology.

Platelets and Thrombosis Impact of Chronic Kidney Disease on Platelet Function Profiles in Diabetes Mellitus Patients With Coronary Artery Disease Taking Dual Antiplatelet Therapy

Masafumi Ueno, C. Macaya, A. Fernández-Ortiz, 2022 .

Vascular brachytherapy using a beta emitter source in diabetic patients with in-stent restenosis: angiographic and clinical outcomes.

P. Teirstein, W. Laskey, S. Silber, 2003, International journal of radiation oncology, biology, physics.

Assessment of potential relationship between wall shear stress and arterial wall response after bare metal stent and sirolimus-eluting stent implantation in patients with diabetes mellitus

C. Macaya, M. Sabaté, D. Angiolillo, 2008, The International Journal of Cardiovascular Imaging.

Heterogeneity of atherosclerotic plaque characteristics in human coronary artery disease: A three‐dimensional intravascular ultrasound study

D. Angiolillo, M. Costa, T. Bass, 2007, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

P1930Pharmacodynamic effects of vorapaxar as an add-on antiplatelet therapy in patients with and without diabetes mellitus: the optimizing anti-platelet therapy in diabetes mellitus (OPTIMUS)-5 study

V. Kairouz, D. Angiolillo, F. Franchi, 2019, European Heart Journal.

Understanding the basics of clinical imaging for assessing stem cell therapy in the heart

M. Costa, T. Bass, 2006 .

Antiplatelet drug response variability and the role of platelet function testing: A practical guide for interventional cardiologists

D. Angiolillo, Luis A. Guzmán, T. Bass, 2009, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Aspirin desensitization in patients undergoing percutaneous coronary interventions with stent implantation.

A. Gavazzi, G. Musumeci, R. Rossini, 2008, The American journal of cardiology.

Impact of aspirin dose on adenosine diphosphate-mediated platelet activities

D. Angiolillo, F. Franchi, F. Rollini, 2013, Thrombosis and Haemostasis.

Effects of pioglitazone on platelet P2Y12-mediated signalling in clopidogrel-treated patients with type 2 diabetes mellitus

Masafumi Ueno, D. Angiolillo, F. Rollini, 2012, Thrombosis and Haemostasis.

A head-to-head pharmacodynamic comparison of prasugrel vs. ticagrelor after switching from clopidogrel in patients with coronary artery disease: results of a prospective randomized study.

D. Angiolillo, F. Franchi, F. Rollini, 2016, European heart journal.

Prasugrel: a novel platelet ADP P2Y12 receptor antagonist. A review on its mechanism of action and clinical development

D. Angiolillo, T. Bass, S. Suryadevara, 2008 .

Pharmacodynamic Effects of Concomitant Versus Staggered Clopidogrel and Omeprazole Intake: Results of a Prospective Randomized Crossover Study

Masafumi Ueno, D. Angiolillo, D. Capodanno, 2010, Circulation. Cardiovascular interventions.

Clinical profile of prasugrel, a novel thienopyridine.

D. Angiolillo, E. Bates, T. Bass, 2008, American heart journal.

The RENEW Trial: Efficacy and Safety of Intramyocardial Autologous CD34(+) Cell Administration in Patients With Refractory Angina.

T. Henry, R. Schatz, D. Stewart, 2016, JACC. Cardiovascular interventions.

Post‐PCI cardiac events? The answer is the lumen, or is it in the wall?

T. Bass, 2002, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Pharmacodynamic Evaluation of Pantoprazole Therapy on Clopidogrel Effects: Results of a Prospective, Randomized, Crossover Study

Masafumi Ueno, D. Angiolillo, D. Capodanno, 2011, Circulation. Cardiovascular interventions.

Impact of gastric acid-suppressing therapies on platelet reactivity in patients with coronary artery disease treated with clopidogrel: results of a pharmacodynamic study.

Masafumi Ueno, D. Angiolillo, D. Capodanno, 2011, Journal of the American College of Cardiology.

Pharmacodynamic Evaluation of Pantoprazole Therapy on Clopidogrel EffectsClinical Perspective

Masafumi Ueno, D. Angiolillo, D. Capodanno, 2011 .

Crushed Prasugrel Tablets in Patients With STEMI Undergoing Primary Percutaneous Coronary Intervention: The CRUSH Study.

D. Angiolillo, F. Franchi, F. Rollini, 2016, Journal of the American College of Cardiology.

Pharmacodynamic Effects of Switching From Prasugrel to Ticagrelor: Results of the Prospective, Randomized SWAP-3 Study.

L. Been, D. Angiolillo, F. Franchi, 2016, JACC. Cardiovascular interventions.

Influence of the CD14 C260T promoter polymorphism on C-reactive protein levels in patients with coronary artery disease.

E. Trabetti, P. Pignatti, C. Macaya, 2006, The American journal of cardiology.

Is CABG Superior to DES for Repeat Revascularization in Patients With Isolated Proximal LAD Disease?

D. Angiolillo, F. Franchi, F. Rollini, 2022 .

Separation of afterload reduction and a direct beneficial cardiac effect of nifedipine in congestive cardiomyopathy

D. Conetta, T. Bass, R. Percy, 1989, Clinical cardiology.

Pharmacodynamic and Pharmacokinetic Effects of a Low Maintenance Dose Ticagrelor Regimen Versus Standard Dose Clopidogrel in Diabetes Mellitus Patients Without Previous Major Cardiovascular Events Undergoing Elective Percutaneous Coronary Intervention: The OPTIMUS-6 Study.

L. Been, D. Angiolillo, F. Franchi, 2020, Circulation.

Impact of Escalating Loading Dose Regimens of Ticagrelor in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: Results of a Prospective Randomized Pharmacokinetic and Pharmacodynamic Investigation.

D. Angiolillo, F. Franchi, F. Rollini, 2015, JACC. Cardiovascular interventions.

Use of Impella Recover LP 2.5 in elective high risk percutaneous coronary intervention.

Á. Cequier, D. Angiolillo, J. Ferreiro, 2010, International journal of cardiology.

Influence of aspirin resistance on platelet function profiles in patients on long-term aspirin and clopidogrel after percutaneous coronary intervention.

C. Macaya, A. Fernández-Ortiz, M. Sabaté, 2006, The American journal of cardiology.

Health Care Reform Bill H. R. 3200--America's Affordable Health Choices Act: what is missing?

T. Bass, J. George, 2009, JACC. Cardiovascular interventions.

Impact of Cigarette Smoking on P2Y12 Receptor Binding Activity Before and After Clopidogrel Therapy in Patients with Coronary Artery Disease

M. Haas, D. Angiolillo, F. Franchi, 2014, Journal of Cardiovascular Translational Research.

Pharmacodynamic Effects of Vorapaxar in Prior Myocardial Infarction Patients Treated With Potent Oral P2Y12 Receptor Inhibitors With and Without Aspirin: Results of the VORA‐PRATIC Study

L. Been, R. Mehran, U. Baber, 2020, Journal of the American Heart Association.

Restenosis after coronary angioplasty: a multivariate statistical model to relate lesion and procedure variables to restenosis. The M-HEART Investigators.

M. Savage, S. Goldberg, J. Hirshfeld, 1991, Journal of the American College of Cardiology.

High speed rotational atherectomy: outcome in calcified and noncalcified coronary artery lesions.

M. Leon, M. Buchbinder, P. Whitlow, 1995, Journal of the American College of Cardiology.

Impact of Timing of Pharmacodynamic Assessment on Platelet Reactivity in Patients Treated With Cangrelor.

L. Been, D. Angiolillo, F. Franchi, 2021, JACC. Cardiovascular interventions.

Pharmacodynamic Effects of Switching From Ticagrelor to Clopidogrel in Patients With Coronary Artery Disease Results of the SWAP (Switching Antiplatelet Therapy)-4 Study

J. Moon, D. Angiolillo, F. Franchi, 2018 .

Clinical and angiographic determinants of primary coronary angioplasty success

M. Savage, S. Goldberg, J. Hirshfeld, 1991 .

Pharmacodynamic effects of prasugrel dosing regimens in patients on maintenance prasugrel therapy: results of a prospective randomized study.

Masafumi Ueno, D. Angiolillo, J. Ferreiro, 2012, Journal of the American College of Cardiology.

Left main coronary artery: We are getting closer

T. Bass, 2004, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

High-Risk Percutaneous Coronary Interventions in Modern Day Clinical Practice: Current Concepts and Challenges.

T. Bass, 2015, Circulation. Cardiovascular interventions.

Standard versus low-dose weight-adjusted heparin in patients treated with the platelet glycoprotein IIb/IIIa receptor antibody fragment abciximab (c7E3 Fab) during percutaneous coronary revascularization. PROLOG Investigators.

R. Califf, P. Teirstein, E. Topol, 1997, The American journal of cardiology.

Functional effects of high clopidogrel maintenance dosing in patients with inadequate platelet inhibition on standard dose treatment.

D. Angiolillo, M. Costa, S. Shoemaker, 2008, The American journal of cardiology.

Platelet Inhibition With Cangrelor and Crushed Ticagrelor in Patients With ST-Segment–Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: Results of the CANTIC Study

L. Been, D. Angiolillo, F. Franchi, 2019, Circulation.

Two-year clinical follow-up of 90Sr/90 Y β-radiation versus placebo control for the treatment of in-stent restenosis

Samin K. Sharma, P. Teirstein, W. O’Neill, 2005 .

Two-year clinical follow-up of Sr/Y h-radiation versus placebo control for the treatment of in-stent restenosis

Samin K. Sharma, P. Teirstein, S. Silber, 2005 .

Impact of timing from blood sampling to pharmacodynamic assessment on measures of platelet reactivity in patients treated with P2Y12 receptor inhibitors

D. Angiolillo, F. Franchi, F. Rollini, 2016, Thrombosis and Haemostasis.

Comparative clinical and angiographic findings in patients with symptomatic and asymptomatic restenosis following angioplasty

M. Savage, S. Goldberg, J. Hirshfeld, 1990 .

Impact of prasugrel reload dosing regimens on high on-treatment platelet reactivity rates in patients on maintenance prasugrel therapy.

Masafumi Ueno, D. Angiolillo, F. Rollini, 2013, JACC. Cardiovascular interventions.

Platelet P2Y12 inhibiting therapy in adjunct to vascular dose of rivaroxaban or aspirin: A pharmacodynamic study of dual pathway inhibition versus dual antiplatelet therapy.

L. Been, D. Angiolillo, T. Geisler, 2022, European heart journal. Cardiovascular pharmacotherapy.

Pharmacodynamic profiles of dual-pathway inhibition with or without clopidogrel vs dual antiplatelet therapy in patients with atherosclerotic disease

L. Been, D. Angiolillo, T. Geisler, 2022, Thrombosis and Haemostasis.

Saphenous vein graft disease.

D. Angiolillo, M. Costa, T. Bass, 2004, Minerva cardioangiologica.

Percutaneous Coronary Intervention Versus Coronary Artery Bypass Graft Surgery in Left Main Coronary Artery Disease

G. Stone, M. Morice, D. Capodanno, 2011 .

Challenges for Expanded Use of Transcatheter Aortic Valve Replacement.

T. Bass, Andres M Pineda, 2017, Circulation. Cardiovascular interventions.

CORONARY ARTERY DISEASE Original Studies Long-Term Clinical Outcomes After Drug-Eluting Stent Implantation in Unprotected Left Main Coronary Artery Disease

D. Angiolillo, Luis A. Guzmán, T. Bass, 2009 .

Intravascular ultrasound characterization of the "black hole" phenomenon after drug-eluting stent implantation.

P. Teirstein, J. Moses, M. Leon, 2006, The American journal of cardiology.

Percutaneous Coronary Interventions for Chronic Total Occlusions: As the Technology Expands, Our Responsibilities Increase.

T. Bass, 2017, Circulation.

Does the cutting balloon make the final cut?

T. Bass, 2002, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Complete versus incomplete revascularization in patients with multivessel disease undergoing percutaneous coronary intervention with drug‐eluting stents

K. Dimopoulos, D. Angiolillo, Luis A. Guzmán, 2008, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Variability in platelet aggregation following sustained aspirin and clopidogrel treatment in patients with coronary heart disease and influence of the 807 C/T polymorphism of the glycoprotein Ia gene.

E. Trabetti, P. Pignatti, C. Macaya, 2005, The American journal of cardiology.

Antithrombotic treatment in vein graft interventions

Luis A. Guzmán, T. Bass, 2008 .

Impact of pentoxifylline on platelet function profiles in patients with type 2 diabetes mellitus and coronary artery disease on dual antiplatelet therapy with aspirin and clopidogrel.

Masafumi Ueno, D. Angiolillo, D. Capodanno, 2011, JACC. Cardiovascular interventions.

Single site experience with high‐speed coronary rotational atherectomy

D. Conetta, Alan Miller, P. Gilmore, 1993, Clinical cardiology.

Impact of academic year timing on percutaneous coronary intervention outcomes at training institutions.

Sunil V. Rao, J. Messenger, P. O'Gara, 2014, Journal of the American College of Cardiology.

Mechanical thrombectomy to the RESCUE

T. Bass, 2002, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Drug‐eluting stents: Not how many, but how long?

T. Bass, 2005 .

Platelet function profiles in patients with type 2 diabetes and coronary artery disease on combined aspirin and clopidogrel treatment.

C. Macaya, A. Fernández-Ortiz, M. Sabaté, 2005, Diabetes.

Lack of association between gene sequence variations of platelet membrane receptors and aspirin responsiveness detected by the PFA-100 system in patients with coronary artery disease

E. Trabetti, P. Pignatti, C. Macaya, 2006, Platelets.

Hemodynamic complications of ventricular septal rupture after acute myocardial infarction

S. Lavine, P. Gilmore, T. Bass, 2003, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Operator radiation exposure and physical discomfort during a right versus left radial approach for coronary interventions: a randomized evaluation.

D. Angiolillo, M. Zenni, Luis A. Guzmán, 2013, JACC. Cardiovascular interventions.

Managing patients with intermediate in-stent restenotic lesions: is it "prime time" for intravascular ultrasound imaging?

T. Bass, P. Capranzano, 2008, Circulation. Cardiovascular interventions.

Sublingual nifedipine: acute effects in severe chronic congestive heart failure secondary to idiopathic dilated cardiomyopathy.

D. Conetta, T. Bass, A. Miller, 1985, The American journal of cardiology.

Functional profile of the platelet P2Y12 receptor signalling pathway in patients with type 2 diabetes mellitus and coronary artery disease

Masafumi Ueno, D. Angiolillo, D. Capodanno, 2011, Thrombosis and Haemostasis.

Should endovascular approach be the first line of treatment for retroperitoneal bleeding with hemodynamic shock following percutaneous intervention? A case series

D. Angiolillo, M. Zenni, Luis A. Guzmán, 2017, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Clinical and angiographic determinants of primary coronary angioplasty success. M-HEART Investigators.

M. Savage, S. Goldberg, J. Hirshfeld, 1991, Journal of the American College of Cardiology.

Autologous CD34+ Cell Therapy for Refractory Angina: 2-Year Outcomes from the ACT34-CMI Study

Amit N. Patel, T. Henry, R. Schatz, 2016, Cell transplantation.

Vascular effects of sirolimus-eluting versus bare-metal stents in diabetic patients: three-dimensional ultrasound results of the Diabetes and Sirolimus-Eluting Stent (DIABETES) Trial.

F. Fernández‐Avilés, C. Macaya, M. Sabaté, 2006, Journal of the American College of Cardiology.

Abstract 5638: Autologous CD34+ Cell Therapy for Refractory Angina: 12 Month Results of the Phase II ACT34-CMI Study

A. Yeung, R. Strumpf, T. Henry, 2009 .

Is It “Prime Time” for Intravascular Ultrasound Imaging?

T. Bass, P. Capranzano, 2008 .

The Challenges Involving Assessing Percutaneous Coronary Intervention Outcomes in Safety-Net Hospitals.

T. Bass, 2017, JACC. Cardiovascular interventions.

Effects of the Peripheral Opioid Receptor Antagonist Methylnaltrexone on the PK and PD Profiles of Ticagrelor in Patients With Coronary Artery Disease Treated With Morphine.

L. Been, D. Angiolillo, F. Franchi, 2019, JACC. Cardiovascular interventions.

Clopidogrel withdrawal is associated with proinflammatory and prothrombotic effects in patients with diabetes and coronary artery disease.

C. Macaya, A. Fernández-Ortiz, M. Sabaté, 2006, Diabetes.

711-3-A Multicenter, Randomized, Double-Blind Pilot Trial of Standard Versus Low Dose Weight-Adjusted Heparin in Patients Treated with the Platelet GP IIb/IIIa Receptor Antibody c7E3 During Percutaneous Coronary Revascularization

R. Califf, P. Teirstein, E. Topol, 1995 .

Pharmacogenetics in cardiovascular antithrombotic therapy.

D. Angiolillo, F. Marín, T. Bass, 2009, Journal of the American College of Cardiology.

Intramyocardial, Autologous CD34+ Cell Therapy for Refractory Angina

T. Henry, R. Schatz, T. Povsic, 2011, Circulation research.

ACCF/AHA/SCAI 2013 update of the clinical competence statement on coronary artery interventional procedures: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training (Writing Committee to Revise

I. Piña, J. Messenger, V. Chair, 2013, Journal of the American College of Cardiology.

Identification of low responders to a 300-mg clopidogrel loading dose in patients undergoing coronary stenting.

C. Macaya, A. Fernández-Ortiz, M. Sabaté, 2005, Thrombosis research.

Sirolimus-eluting stent for the treatment of bypass graft disease: The initial U.S. Experience

P. Teirstein, J. Moses, M. Leon, 2003 .

Transluminal angioplasty of anomalous coronary arteries.

M. Rubin, T. Bass, A. Miller, 1986, American heart journal.

Contribution of Gene Sequence Variations of the Hepatic Cytochrome P450 3A4 Enzyme to Variability in Individual Responsiveness to Clopidogrel

E. Trabetti, P. Pignatti, C. Macaya, 2006, Arteriosclerosis, thrombosis, and vascular biology.

Restenosis after coronary angioplasty: A multilvariate statistical model to relate lesion and procedure variables to restenosis☆

M. Savage, S. Goldberg, J. Hirshfeld, 1991 .

S. Goldberg, J. Hirshfeld, G. Vetrovec, 1990, The American journal of cardiology.

A controlled trial of corticosteroids to prevent restenosis after coronary angioplasty. M-HEART Group.

M. Savage, S. Goldberg, J. Hirshfeld, 1990, Circulation.

Sr/Y -Radiation Versus Placebo Control for Treatment of In-Stent Restenosis

P. Teirstein, S. Silber, M. Suntharalingam, 2002 .

Randomized Trial of 90 Sr / 90 Y-Radiation Versus Placebo Control for Treatment of In-Stent Restenosis

P. Teirstein, S. Silber, M. Suntharalingam, 2002 .

Randomized Trial of 90Sr/90Y β-Radiation Versus Placebo Control for Treatment of In-Stent Restenosis

Richard R. Heuser, Theodore A. Bass, Jeffrey J. Popma, 2002 .

Caught between a rock and a hard place? It is good to have some help

T. Bass, 2002, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Atherectomy prior to stenting bifurcation lesions: A fork in the road, which direction do we choose?

T. Bass, 2001, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Results of the study to determine rotablator and transluminal angioplasty strategy (STRATAS).

R. Bersin, J. Moses, David O. Williams, 2001, The American journal of cardiology.

Rotational atherectomy in anomalous coronary arteries.

P. Gilmore, T. Bass, E. Ceithaml, 1992, Catheterization and cardiovascular diagnosis.

Effects of Sirolimus-Eluting ersus Bare-Metal Stents in Diabetic Patients hree-Dimensional Ultrasound Results of the Diabetes nd Sirolimus-Eluting Stent ( DIABETES ) Trial ilar

C. Macaya, M. Sabaté, D. Angiolillo, 2006 .

[Assessment of dynamic coronary plaque changes and the clinical consequences in type-II diabetic patients: a serial intracoronary ultrasound study].

C. Macaya, M. Sabaté, D. Angiolillo, 2011, Revista espanola de cardiologia.

Vessel Shrinkage as a Sign of Atherosclerosis Progression in Type 2 Diabetes

C. Macaya, M. Sabaté, D. Angiolillo, 2009, Diabetes.

Lack of association between the P2Y12 receptor gene polymorphism and platelet response to clopidogrel in patients with coronary artery disease.

E. Trabetti, P. Pignatti, C. Macaya, 2005, Thrombosis research.

The QUinapril Ischemic Event Trial (QUIET): evaluation of chronic ACE inhibitor therapy in patients with ischemic heart disease and preserved left ventricular function.

R. Lees, B. Pitt, R. Ferrari, 2001, The American journal of cardiology.

Impact of stent deployment procedural factors on long-term effectiveness and safety of sirolimus-eluting stents (final results of the multicenter prospective STLLR trial).

Theodore A Bass, D. Angiolillo, M. Tannenbaum, 2008, The American journal of cardiology.

Randomized Comparison of a High Clopidogrel Maintenance Dose in Patients With Diabetes Mellitus and Coronary Artery Disease: Results of the Optimizing Antiplatelet Therapy in Diabetes Mellitus (OPTIMUS) Study

D. Angiolillo, M. Costa, S. Shoemaker, 2007, Circulation.

Insulin therapy is associated with platelet dysfunction in patients with type 2 diabetes mellitus on dual oral antiplatelet treatment.

C. Macaya, A. Fernández-Ortiz, M. Sabaté, 2006, Journal of the American College of Cardiology.

Diagnostic accuracy of quantitative cardiac MRI evaluation compared to stress single-photon-emission computed tomography

N. Wilke, D. Angiolillo, M. Costa, 2008, The International Journal of Cardiovascular Imaging.

2023 ACC/AHA/SCAI Advanced Training Statement on Interventional Cardiology (Coronary, Peripheral Vascular, and Structural Heart Interventions): A Report of the ACC Competency Management Committee.

M. Rich, E. Mahmud, A. Denktas, 2023, Circulation. Cardiovascular interventions.

Candidates for transcatheter aortic valve replacement

S. Lavine, J. Strom, Luis A. Guzmán, 2013, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Interventional Cardiology US Workforce: current challenges.

T. Bass, 2014, Circulation. Cardiovascular interventions.

Pharmacodynamic effects of standard dose prasugrel versus high dose clopidogrel in non-diabetic obese patients with coronary artery disease

Masafumi Ueno, D. Angiolillo, F. Rollini, 2013, Thrombosis and Haemostasis.

A Systematic Review of Outcomes in Patients With Staged Carotid Artery Stenting and Coronary Artery Bypass Graft Surgery

P. Wludyka, D. Angiolillo, S. Silliman, 2008, Stroke.

Pharmacodynamic Comparison of Prasugrel Versus Ticagrelor in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease: The OPTIMUS (Optimizing Antiplatelet Therapy in Diabetes Mellitus)-4 Study

L. Been, D. Angiolillo, F. Rollini, 2016, Circulation.

Reply: elevated serum fibrinogen: an independent link between diabetes mellitus, impaired on-clopidogrel platelet inhibition, and major adverse cardiac events after percutaneous coronary intervention.

D. Angiolillo, F. Rollini, T. Bass, 2015, Journal of the American College of Cardiology.

Impact of renal function on clopidogrel-induced antiplatelet effects in coronary artery disease patients without diabetes mellitus

Masafumi Ueno, D. Angiolillo, D. Capodanno, 2013, Journal of Thrombosis and Thrombolysis.

A randomized study assessing the impact of cilostazol on platelet function profiles in patients with diabetes mellitus and coronary artery disease on dual antiplatelet therapy: results of the OPTIMUS-2 study.

S. Goto, D. Angiolillo, S. Shoemaker, 2008, European heart journal.

Impact of platelet reactivity on cardiovascular outcomes in patients with type 2 diabetes mellitus and coronary artery disease.

C. Macaya, A. Fernández-Ortiz, M. Sabaté, 2007, Journal of the American College of Cardiology.

Revascularization for unprotected left main disease: evolution of the evidence basis to redefine treatment standards.

P. Teirstein, G. Stone, Seung‐Jung Park, 2009, Journal of the American College of Cardiology.

Relocation of minimal luminal diameter after bare metal and drug‐eluting stent implantation: Incidence and impact on angiographic late loss

C. Macaya, M. Sabaté, D. Angiolillo, 2007, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Functional impact of high clopidogrel maintenance dosing in patients undergoing elective percutaneous coronary interventions

C. Macaya, A. Fernández-Ortiz, D. Angiolillo, 2007, Thrombosis and Haemostasis.

Angiographic and 3D intravascular ultrasound assessment of overlapping bare metal stent and three different formulations of drug-eluting stents in patients with diabetes mellitus

C. Macaya, M. Sabaté, D. Angiolillo, 2008, The International Journal of Cardiovascular Imaging.

Myocardial infarction during pregnancy: management with transluminal coronary angioplasty and metallic intracoronary stents.

C. Adair, T. Bass, L. Sanchez-Ramos, 1994, American journal of obstetrics and gynecology.

Evaluation of cardiac magnetic resonance imaging parameters to detect anatomically and hemodynamically significant coronary artery disease.

N. Wilke, D. Angiolillo, F. von Ziegler, 2007, American heart journal.

Intravascular ultrasound catheter entrapment after coronary artery stenting

M. Costa, P. Gilmore, T. Bass, 2002, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

CLINICAL RESEARCH Interventional Cardiology Characterization of Plaque Prolapse After Drug-Eluting Stent Implantation in Diabetic Patients A Three-Dimensional Volumetric Intravascular Ultrasound Outcome Study

C. Macaya, M. Sabaté, D. Angiolillo, 2006 .

Treatment of Left Anterior Descending Coronary Artery Disease With Sirolimus-Eluting Stents

P. Teirstein, J. Moses, M. Leon, 2004, Circulation.

Pharmacodynamic Effects of Switching From Ticagrelor to Clopidogrel in Patients With Coronary Artery Disease: Results of the SWAP-4 Study

L. Been, J. Moon, D. Angiolillo, 2018, Circulation.

Correlation of paradoxical atrial septal motion and an interatrial pressure gradient in severe tricuspid regurgitation.

E. Geiser, D. Conetta, C. Conti, 1985, The American journal of cardiology.

2023 ACC/AHA/SCAI Advanced Training Statement on Interventional Cardiology (Coronary, Peripheral Vascular, and Structural Heart Interventions): A Report of the ACC Competency Management Committee.

M. Rich, E. Mahmud, A. Denktas, 2023, Journal of the American College of Cardiology.

Percutaneous coronary intervention of bifurcation coronary disease.

T A Bass, D. Angiolillo, H. Futamatsu, 2007, Minerva cardioangiologica.

Response to Letter Regarding Article, “Pharmacodynamic Effects of Different Aspirin Dosing Regimens in Type 2 Diabetes Mellitus Patients With Coronary Artery Disease”

Masafumi Ueno, D. Angiolillo, D. Capodanno, 2011 .

“Menage a trois” or “No Mas”

T. Bass, 2006, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Stent thrombosis in the era of drug eluting stents.

D. Angiolillo, H. Futamatsu, T. Bass, 2007, Minerva cardioangiologica.

Appropriate use criteria for cardiac catheterization and coronary revascularization

Jack P. Chen, T. Bass, Thach N. Nguyen, 2014, Chinese medical journal.

Impact of chronic kidney disease on platelet P2Y12 receptor signalling in patients with type 2 diabetes mellitus

D. Angiolillo, F. Rollini, T. Bass, 2016, Thrombosis and Haemostasis.

Overstretching undersized drug‐eluting stents: A temporary solution

T. Bass, 2004, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Abstract 12535: Adjunctive Vorapaxar Therapy in Patients With Prior Myocardial Infarction Treated With Newer Generation P2y12 Receptor Inhibitors Prasugrel and Ticagrelor (VORA-PRATIC): A Prospective, Randomized, Pharmacodynamic Study

L. Been, D. Angiolillo, F. Rollini, 2019 .

In Vitro Pharmacodynamic Effects of Cangrelor on Platelet P2Y12 Receptor-Mediated Signaling in Ticagrelor-Treated Patients.

L. Been, D. Angiolillo, F. Rollini, 2016, JACC. Cardiovascular interventions.

Synergistic use of sirolimus‐eluting stents and intravascular ultrasound for the treatment of unprotected left main and vein graft disease

M. Costa, P. Gilmore, T. Bass, 2004, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Advanced atherosclerotic diseases in multiple vascular bed sites

Luis A. Guzmán, T. Bass, 2007 .

Randomized Trial of 90Sr/90Y &bgr;-Radiation Versus Placebo Control for Treatment of In-Stent Restenosis

P. Teirstein, S. Silber, M. Suntharalingam, 2002, Circulation.

Brachytherapy for in‐stent restenosis: The problem is one of commitment

T. Bass, 2003, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Quality initiatives in the cardiac catheterization and interventional laboratories

T. Bass, Thach N. Nguyen, F. Latif, 2014, Chinese medical journal.

Is an aggressive rotablator strategy preferable to a standard rotablator strategy in patients with heavily calcified coronary lesions? a report from the STRATAS trial

David O. Williams, K. Ho, R. Kuntz, 1998 .

A Pharmacodynamic Comparison of Prasugrel Versus Ticagrelor in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease : The OPTIMUS ( Optimizing Antiplatelet Therapy in Diabetes Mellitus )-4 Study

D. Angiolillo, F. Rollini, T. Bass, 2016 .

Sirolimus-eluting stents for treatment of complex bypass graft disease: insights from the SECURE registry.

P. Teirstein, J. Moses, M. Leon, 2005, The Journal of invasive cardiology.

A head-to-head pharmacodynamic comparison of prasugrel vs. ticagrelor after switching from clopidogrel in patients with coronary artery disease: results of a prospective randomized study.

D. Angiolillo, F. Rollini, Luis A. Guzmán, 2016, European heart journal.

L. Been, D. Angiolillo, F. Rollini, 2016, Circulation.

Impact of aspirin dose on adenosine diphosphate-mediated platelet activities

D. Angiolillo, F. Rollini, A. Tello-Montoliu, 2013, Thrombosis and Haemostasis.

Antiplatelet drug response variability and the role of platelet function testing: A practical guide for interventional cardiologists

D. Angiolillo, Luis A. Guzmán, T. Bass, 2009, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

S. Goto, D. Angiolillo, S. Shoemaker, 2008, European heart journal.

Functional effects of high clopidogrel maintenance dosing in patients with inadequate platelet inhibition on standard dose treatment.

D. Angiolillo, M. Costa, S. Shoemaker, 2008, The American journal of cardiology.

2023 ACC/AHA/SCAI advanced training statement on interventional cardiology (coronary, peripheral vascular, and structural heart interventions): A report of the ACC Competency Management Committee.

M. Rich, E. Mahmud, A. Denktas, 2023, The Journal of thoracic and cardiovascular surgery.

2023 ACC/AHA/SCAI Advanced Training Statement on Interventional Cardiology (Coronary, Peripheral Vascular, and Structural Heart Interventions): A Report of the ACC Competency Management Committee.

M. Rich, E. Mahmud, A. Denktas, 2023, JACC. Cardiovascular interventions.

2023 ACC/AHA/SCAI Advanced Training Statement on Interventional Cardiology (Coronary, Peripheral Vascular, and Structural Heart Interventions): A Report of the ACC Competency Management Committee.

M. Rich, E. Mahmud, A. Denktas, 2023, Journal of the American College of Cardiology.

Pharmacodynamic effects of standard dose prasugrel versus high dose clopidogrel in non-diabetic obese patients with coronary artery disease

Masafumi Ueno, D. Angiolillo, F. Rollini, 2013, Thrombosis and Haemostasis.

Impact of adjunctive cilostazol therapy on platelet function profiles in patients with and without diabetes mellitus on aspirin and clopidogrel therapy

Masafumi Ueno, D. Angiolillo, D. Capodanno, 2011, Thrombosis and Haemostasis.

CORONARY ARTERY DISEASE Original Studies Relocation of Minimal Luminal Diameter After Bare Metal and Drug-Eluting Stent Implantation: Incidence and Impact on Angiographic Late Loss

C. Macaya, M. Sabaté, D. Angiolillo, 2007 .

C. Macaya, M. Sabaté, D. Angiolillo, 2006 .

Long‐term clinical outcomes after drug‐eluting stent implantation in unprotected left main coronary artery disease

D. Angiolillo, T. Bass, C. Tamburino, 2009, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Pharmacodynamic Effects of Concomitant Versus Staggered Clopidogrel and Omeprazole Intake: Results of a Prospective Randomized Crossover Study

Masafumi Ueno, D. Angiolillo, D. Capodanno, 2010, Circulation. Cardiovascular interventions.